A Study to Assess Efficacy and Safety of Baxdrostat in Participants With Primary Aldosteronism

Abroad (travel likely)RecruitingPHASE3

Conditions

Primary Hyperaldosteronism

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations
  • Research Site, Los Angeles, California, United States

  • Research Site, San Francisco, California, United States

  • Research Site, Farmington, Connecticut, United States

  • Research Site, Chicago, Illinois, United States

  • Research Site, Springfield, Illinois, United States

  • Research Site, Baltimore, Maryland, United States

  • Research Site, Boston, Massachusetts, United States

  • Research Site, Boston, Massachusetts, United States

  • Research Site, Ann Arbor, Michigan, United States

  • Research Site, Rochester, Minnesota, United States

  • Research Site, Olive Branch, Mississippi, United States

  • Research Site, Kansas City, Missouri, United States

  • Research Site, New York, New York, United States

  • Research Site, Cleveland, Ohio, United States

  • Research Site, Columbus, Ohio, United States

  • Research Site, Portland, Oregon, United States

  • Research Site, Bethlehem, Pennsylvania, United States

  • Research Site, Philadelphia, Pennsylvania, United States

  • Research Site, Columbia, South Carolina, United States

  • Research Site, Brownsville, Texas, United States

  • Research Site, Dallas, Texas, United States

  • Research Site, Brisbane, Australia

  • Research Site, Clayton, Australia

  • Research Site, Perth, Australia

  • Research Site, Calgary, Alberta, Canada

  • Research Site, Ottawa, Ontario, Canada

  • Research Site, Toronto, Ontario, Canada

  • Research Site, Montreal, Quebec, Canada

  • Research Site, Beijing, China

  • Research Site, Beijing, China

  • Research Site, Beijing, China

  • Research Site, Changsha, China

  • Research Site, Chengdu, China

  • Research Site, Chengdu, China

  • Research Site, Chongqing, China

  • Research Site, Nanjing, China

  • Research Site, Shanghai, China

  • Research Site, Tianjin, China

  • Research Site, Wuhan, China

  • Research Site, Wuhan, China

  • Research Site, Xianyang, China

  • Research Site, Amiens, France

  • Research Site, Bois-Guillaume, France

  • Research Site, Bordeaux, France

  • Research Site, Lille, France

  • Research Site, Marseille, France

  • Research Site, Paris, France

  • Research Site, Paris, France

  • Research Site, Berlin, Germany

  • Research Site, Düsseldorf, Germany

  • Research Site, Kaiserslautern, Germany

  • Research Site, München, Germany

  • Research Site, Reinfeld (Holstein), Germany

  • Research Site, Würzburg, Germany

  • Research Site, Belagavi, India

  • Research Site, Delhi, India

  • Research Site, Hyderabad, India

  • Research Site, Kolkata, India

  • Research Site, Mumbai, India

  • Research Site, Mumbai, India

  • Research Site, Bologna, Italy

  • Research Site, Brescia, Italy

  • Research Site, Florence, Italy

  • Research Site, Milan, Italy

  • Research Site, Milan, Italy

  • Research Site, Torino, Italy

  • Research Site, Kawasaki-shi, Japan

  • Research Site, Kodaira-shi, Japan

  • Research Site, Minatoku, Japan

  • Research Site, Ōta-ku, Japan

  • Research Site, Shinjuku-ku, Japan

  • Research Site, Yokohama, Japan

  • Research Site, Yufu-shi, Japan

  • Research Site, Barcelona, Spain

  • Research Site, Madrid, Spain

  • Research Site, Madrid, Spain

  • Research Site, Madrid, Spain

  • Research Site, Seville, Spain

  • Research Site, Kaohsiung City, Taiwan

  • Research Site, Taichung, Taiwan

  • Research Site, Taipei, Taiwan

  • Research Site, Taoyuan, Taiwan

  • Research Site, Yunlin, Taiwan

  • Research Site, Zhubei, Taiwan

  • Research Site, Cambridge, United Kingdom

  • Research Site, Cardiff, United Kingdom

  • Research Site, Dundee, United Kingdom

  • Research Site, London, United Kingdom

  • Research Site, London, United Kingdom